Nanotechnology Now

Our NanoNews Digest Sponsors







Heifer International

Wikipedia Affiliate Button


Home > Press > MIT engineers design new nanoparticle that could lead to vaccines for HIV, malaria, other diseases

Abstract:
MIT engineers have designed a new type of nanoparticle that could safely and effectively deliver vaccines for diseases such as HIV and malaria.

by Anne Trafton, MIT News Office

MIT engineers design new nanoparticle that could lead to vaccines for HIV, malaria, other diseases

Cambridge, MA | Posted on February 22nd, 2011

The new particles, described in the Feb. 20 issue of Nature Materials, consist of concentric fatty spheres that can carry synthetic versions of proteins normally produced by viruses. These synthetic particles elicit a strong immune response — comparable to that produced by live virus vaccines — but should be much safer, says Darrell Irvine, author of the paper and an associate professor of materials science and engineering and biological engineering.

Such particles could help scientists develop vaccines against cancer as well as infectious diseases. In collaboration with scientists at the Walter Reed Army Institute of Research, Irvine and his students are now testing the nanoparticles' ability to deliver an experimental malaria vaccine in mice.

Vaccines protect the body by exposing it to an infectious agent that primes the immune system to respond quickly when it encounters the pathogen again. In many cases, such as with the polio and smallpox vaccines, a dead or disabled form of the virus is used. Other vaccines, such as the diphtheria vaccine, consist of a synthetic version of a protein or other molecule normally made by the pathogen.

When designing a vaccine, scientists try to provoke at least one of the human body's two major players in the immune response: T cells, which attack body cells that have been infected with a pathogen; or B cells, which secrete antibodies that target viruses or bacteria present in the blood and other body fluids.

For diseases in which the pathogen tends to stay inside cells, such as HIV, a strong response from a type of T cell known as "killer" T cell is required. The best way to provoke these cells into action is to use a killed or disabled virus, but that cannot be done with HIV because it's difficult to render the virus harmless.

To get around the danger of using live viruses, scientists are working on synthetic vaccines for HIV and other viral infections such as hepatitis B. However, these vaccines, while safer, do not elicit a very strong T cell response. Recently, scientists have tried encasing the vaccines in fatty droplets called liposomes, which could help promote T cell responses by packaging the protein in a virus-like particle. However, these liposomes have poor stability in blood and body fluids.

Irvine, who is a member of MIT's David H. Koch Institute for Integrative Cancer Research, decided to build on the liposome approach by packaging many of the droplets together in concentric spheres. Once the liposomes are fused together, adjacent liposome walls are chemically "stapled" to each other, making the structure more stable and less likely to break down too quickly following injection. However, once the nanoparticles are absorbed by a cell, they degrade quickly, releasing the vaccine and provoking a T cell response.

In tests with mice, Irvine and his colleagues used the nanoparticles to deliver a protein called ovalbumin, an egg-white protein commonly used in immunology studies because biochemical tools are available to track the immune response to this molecule. They found that three immunizations of low doses of the vaccine produced a strong T cell response — after immunization, up to 30 percent of all killer T cells in the mice were specific to the vaccine protein.

That is one of the strongest T cell responses generated by a protein vaccine, and comparable to strong viral vaccines, but without the safety concerns of live viruses, says Irvine. Importantly, the particles also elicit a strong antibody response.

In addition to the malaria studies with scientists at Walter Reed, Irvine is also working on developing the nanoparticles to deliver cancer vaccines and HIV vaccines. Translation of this approach to HIV is being done in collaboration with colleagues at the Ragon Institute of MIT, Harvard and Massachusetts General Hospital. The institute, which funded this study along with the Gates Foundation, Department of Defense and National Institutes of Health, was established in 2009 with the goal of developing an HIV vaccine.

####

For more information, please click here

Contacts:
Caroline McCall
MIT News Office

T: 617-253-1682

Patti Richards
MIT News Office

T: 617-253-8923

Copyright © MIT

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Sound waves precisely position nanowires June 19th, 2013

Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013

Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013

Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013

Govt.-Legislation/Regulation/Funding/Policy

Sound waves precisely position nanowires June 19th, 2013

3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013

Working backward: Computer-aided design of zeolite templates: Rice scientists apply drug-design lessons to production of industrial minerals June 17th, 2013

An Innovative material for the Green Earth: Simple and inexpensive process to make a material for CO2 adsorption June 17th, 2013

Possible Futures

Space Solar Power: Key to a Livable Planet Earth June 10th, 2013

Global Nanotechnology Drug Delivery Market 2012-2016 June 10th, 2013

Nanorobot tetanus treatment animation June 9th, 2013

New horizons to drive the future of Medicine: European Technology Platform on Nanomedicine intends to lead the domain June 8th, 2013

Academic/Education

CNSE Welcomes Record Number of Students, Majority of Whom are New Yorkers, for Prestigious Summer Internship Program June 12th, 2013

FEI and University of Oklahoma Begin Collaboration Research Agreement for Understanding and Developing Unconventional Oil and Gas Reservoirs: Collaboration effort will focus on new methods to classify shales in the economic assessment of “tight” resource plays June 7th, 2013

Johannes Gutenberg University Mainz obtains new Collaborative Research Center on "Nanodimensional polymer therapeutics for tumor therapy" June 2nd, 2013

Lorraine University uses Nanoparticle Tracking Analysis to characterize biomolecules for agrichemicals, pharmacology and cosmetics May 28th, 2013

Nanomedicine

Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013

3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013

Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013

Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013

Announcements

Sound waves precisely position nanowires June 19th, 2013

Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013

Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013

Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013

Nanobiotechnology

Iranian Scientists Produce Dynamometer for Nanoparticles, Biocells June 15th, 2013

Shape of nanoparticles points the way toward more targeted drugs: A collaboration of scientists at Sanford-Burnham and the University of California, Santa Barbara, finds that rod-shaped particles, rather than spherical particles, appear more effective at adhering to cells June 10th, 2013

Catching individual molecules in a million with optical antennas inside nano-boxes June 10th, 2013

Whispering light hears liquids talk: University of Illinois researchers build first-ever bridge between optomechanics and microfluidics June 7th, 2013

Research partnerships

3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013

Imec presents 4K2K CMOS image sensor together with Panasonic: The co-developed imager sensor chip targets high speed, high resolution imaging applications such as next generation HDTV June 18th, 2013

Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013

Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More












ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project








abbigliamento uomo
Computer Accessories
© Copyright 1999-2013 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE